1.Brinchmann-Hansen O, Dahl-Jorgensen K, Hanssen KF, Sandvik L. The response of diabetic retinopathy to 41 months of multiple insulin injections, insulin pumps, and conventional insulin therapy. Archives of ophthalmology (Chicago, Ill: 1960). 1988;106(9):1242–6.
2.Xie MY, Yang Y, Liu P, Luo Y, Tang SB. 5-aza–2’-deoxycytidine in the regulation of antioxidant enzymes in retinal endothelial cells and rat diabetic retina. International journal of ophthalmology. 2019;12(1):1–7.
3.Obeid A, Su D, Patel SN, Uhr JH, Borkar D, Gao X, et al. Outcomes of Eyes Lost to Follow-up with Proliferative Diabetic Retinopathy That Received Panretinal Photocoagulation versus Intravitreal Anti-Vascular Endothelial Growth Factor. Ophthalmology. 2019;126(3):407–13.
4.Joussen AM, Poulaki V, Mitsiades N, Kirchhof B, Koizumi K, Dohmen S, et al. Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2002;16(3):438–40.
5.Zheng L, Szabo C, Kern TS. Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-kappaB. Diabetes. 2004;53(11):2960–7.
6.Kamble VV KR. Automatic Identification and Classification of Microaneurysms, Exudates and Blood Vessel for Early Diabetic Retinopathy Recognition: Computational Intelligence in Data Mining. 2019.
7.Hemanth DJ DO, Kose U. An enhanced diabetic retinopathy detection and classification approach using deep convolutional neural network. Neural Computing and Applications. 2019(7398):1–15.
8.Thomas AA, Biswas S, Feng B, Chen S, Gonder J, Chakrabarti S. lncRNA H19 prevents endothelial-mesenchymal transition in diabetic retinopathy. Diabetologia. 2019;62(3):517–30.
9.Luo DW, Zheng Z, Wang H, Fan Y, Chen F, Sun Y, et al. UPP mediated Diabetic Retinopathy via ROS/PARP and NF-kappaB inflammatory factor pathways. Current molecular medicine. 2015;15(8):790–9.
10.Chen F, Zhang HQ, Zhu J, Liu KY, Cheng H, Li GL, et al. Puerarin enhances superoxide dismutase activity and inhibits RAGE and VEGF expression in retinas of STZ-induced early diabetic rats. Asian Pacific journal of tropical medicine. 2012;5(11):891–6.
11.Yin Y, Chen F, Wang W, Wang H, Zhang X. Resolvin D1 inhibits inflammatory response in STZ-induced diabetic retinopathy rats: Possible involvement of NLRP3 inflammasome and NF-kappaB signaling pathway. Molecular vision. 2017;23:242–50.
12.Liang Z, Gao KP, Wang YX, Liu ZC, Tian L, Yang XZ, et al. RNA sequencing identified specific circulating miRNA biomarkers for early detection of diabetes retinopathy. American journal of physiology Endocrinology and metabolism. 2018;315(3):E374-e85.
13.Zhang J, Wu L, Chen J, Lin S, Cai D, Chen C, et al. Downregulation of MicroRNA 29a/b exacerbated diabetic retinopathy by impairing the function of Muller cells via Forkhead box protein O4. Diabetes & vascular disease research. 2018;15(3):214–22.
14.Wang W, Lo ACY. Diabetic Retinopathy: Pathophysiology and Treatments. International journal of molecular sciences. 2018;19(6).
15.Sorrentino FS, Matteini S, Bonifazzi C, Sebastiani A, Parmeggiani F. Diabetic retinopathy and endothelin system: microangiopathy versus endothelial dysfunction. Eye (London, England). 2018;32(7):1157–63.
16.Meerson A, Eliraz Y, Yehuda H, Knight B, Crundwell M, Ferguson D, et al. Obesity impacts the regulation of miR–10b and its targets in primary breast tumors. BMC cancer. 2019;19(1):86.
17.Chen PJ, Shang AQ, Yang JP, Wang WW. microRNA–874 inhibition targeting STAT3 protects the heart from ischemia-reperfusion injury by attenuating cardiomyocyte apoptosis in a mouse model. Journal of cellular physiology. 2019;234(5):6182–93.
18.Yao T, Zha D, Gao P, Shui H, Wu X. MiR–874 alleviates renal injury and inflammatory response in diabetic nephropathy through targeting toll-like receptor–4. Journal of cellular physiology. 2018;234(1):871–9.
19.Gong Q, Li F, Xie J, Su G. Upregulated VEGF and Robo4 correlate with the reduction of miR–15a in the development of diabetic retinopathy. Endocrine. 2019.
20.Wang G, Yan Y, Xu N, Hui Y, Yin D. Upregulation of microRNA–424 relieved diabetic nephropathy by targeting Rictor through mTOR Complex2/Protein Kinase B signaling. Journal of cellular physiology. 2019;234(7):11646–53.
21.Berteau F, Rouviere B, Nau A, Le Berre R, Sarrabay G, Touitou I, et al. ‘A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease’. Annals of the rheumatic diseases. 2019;78(5):e35.
22.Aeschlimann FA, Laxer RM. Response to: ‘A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease’ by Aeschlimann et al. Annals of the rheumatic diseases. 2019;78(5):e36.
23.Huang WJ, Wang Y, Liu S, Yang J, Guo SX, Wang L, et al. Retraction notice to “Silencing circular RNA hsa_circ_0000977 suppresses pancreatic ductal adenocarcinoma progression by stimulating miR–874–3p and inhibiting PLK1 expression” [Cancer Letters 422C (2018) 70–80]. Cancer letters. 2018;438:232.
24.Tang W, Wang W, Zhao Y, Zhao Z. MicroRNA–874 inhibits cell proliferation and invasion by targeting cyclin-dependent kinase 9 in osteosarcoma. Oncology letters. 2018;15(5):7649–54.
25.Liao H, Pan Y, Pan Y, Shen J, Qi Q, Zhong L, et al. MicroRNA874 is downregulated in cervical cancer and inhibits cancer progression by directly targeting ETS1. Oncology reports. 2018;40(4):2389–98.
26.Zhang Y, Wang X, Zhao Y. MicroRNA874 prohibits the proliferation and invasion of retinoblastoma cells by directly targeting metadherin. Molecular medicine reports. 2018;18(3):3099–105.
27.Antzelevitch C. Genetic, molecular and cellular mechanisms underlying the J wave syndromes. Cardiac Electrophysiology: from Cell to Bedside. 2018;76(5):483–93.
28.Jiang T, Guan LY, Ye YS, Liu HY, Li R. MiR–874 inhibits metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma by targeting SOX12. American journal of cancer research. 2017;7(6):1310–21.
29.Yang R, Li P, Zhang G, Lu C, Wang H, Zhao G. Long Non-Coding RNA XLOC_008466 Functions as an Oncogene in Human Non-Small Cell Lung Cancer by Targeting miR–874. Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology. 2017;42(1):126–36.
30.Leong KW, Cheng CW, Wong CM, Ng IO, Kwong YL, Tse E. miR–874–3p is down-regulated in hepatocellular carcinoma and negatively regulates PIN1 expression. Oncotarget. 2017;8(7):11343–55.